BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
3.820
+0.100 (2.69%)
At close: Jul 10, 2026, 4:00 PM EDT
3.855
+0.035 (0.92%)
After-hours: Jul 10, 2026, 4:10 PM EDT
BioAtla Market Cap
BioAtla has a market cap or net worth of $6.34 million as of July 10, 2026. Its market cap has decreased by -73.28% in one year.
Market Cap
6.34M
Enterprise Value
10.47M
1-Year Change
-73.28%
Ranking
Category
Stock Price
$3.82
Market Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $9.78B to $6.34M, a decrease of -99.94%. That is a compound annual growth rate of -73.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 6.34M | -81.08% |
| Dec 31, 2025 | 33.51M | -2.30% |
| Dec 31, 2024 | 34.30M | -70.91% |
| Dec 29, 2023 | 117.92M | -86.61% |
| Dec 30, 2022 | 880.59M | -59.20% |
| Dec 31, 2021 | 2.16B | -40.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NextCure | 6.29M |
| Purple Biotech | 6.22M |
| Adial Pharmaceuticals | 6.17M |
| Xenetic Biosciences | 6.12M |
| Pulmatrix | 6.03M |
| Acurx Pharmaceuticals | 5.97M |
| Genprex | 5.97M |
| Curanex Pharmaceuticals | 5.96M |